Mark Frewin
8Patents
4h-index
13Co-inventors
50Inventor score
Filing activity: Oct 9, 2001 → Dec 18, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7465790B2 | Therapeutic antibodies | Chemistry; Metallurgy | 61 | Expired |
| US7993641B2 | Methods of treatment using anti-CD3 antibodies | Chemistry; Metallurgy | 48 | Active |
| US7994289B2 | Humanized anti-CD3 antibodies | Chemistry; Metallurgy | 18 | Expired |
| US8623357B2 | Therapeutic antibodies | Chemistry; Metallurgy | 5 | Active |
| US8440190B2 | Antibody variants | Chemistry; Metallurgy | 3 | Active |
| US7947272B2 | Compositions and methods of tolerizing a primate to an antigen | Chemistry; Metallurgy | 0 | Active |
| US10800850B2 | Therapeutic antibodies | Chemistry; Metallurgy | 0 | Active |
| US7541443B2 | Anti-CD4 antibodies | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.